Salarius Pharmaceuticals, LLC
Decoy Therapeutics develops peptide antivirals designed to target multiple respiratory viruses using its IMP(3)ACT platform, which combines AI-assisted design and rapid synthesis.
8-KSep 23Latest SEC filing, period to Sep 22
Sep 23Latest story